309 related articles for article (PubMed ID: 19763339)
1. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery.
Janga SC; Tzakos A
Mol Biosyst; 2009 Dec; 5(12):1536-48. PubMed ID: 19763339
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
[TBL] [Abstract][Full Text] [Related]
4. Network pharmacology: the next paradigm in drug discovery.
Hopkins AL
Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the role of network and systems biology in drug discovery.
Pujol A; Mosca R; Farrés J; Aloy P
Trends Pharmacol Sci; 2010 Mar; 31(3):115-23. PubMed ID: 20117850
[TBL] [Abstract][Full Text] [Related]
6. Target discovery from data mining approaches.
Yang Y; Adelstein SJ; Kassis AI
Drug Discov Today; 2009 Feb; 14(3-4):147-54. PubMed ID: 19135549
[TBL] [Abstract][Full Text] [Related]
7. Network approaches to drug discovery.
Chandra N; Padiadpu J
Expert Opin Drug Discov; 2013 Jan; 8(1):7-20. PubMed ID: 23140510
[TBL] [Abstract][Full Text] [Related]
8. Network-based drugs and biomarkers.
Erler JT; Linding R
J Pathol; 2010 Jan; 220(2):290-6. PubMed ID: 19921715
[TBL] [Abstract][Full Text] [Related]
9. [Multi-target therapeutics and new drug discovery].
Xu Y; Li XJ
Yao Xue Xue Bao; 2009 Mar; 44(3):226-30. PubMed ID: 19449518
[TBL] [Abstract][Full Text] [Related]
10. High-throughput target discovery using cell-based genetics.
Jackson PD; Harrington JJ
Drug Discov Today; 2005 Jan; 10(1):53-60. PubMed ID: 15676299
[TBL] [Abstract][Full Text] [Related]
11. Network systems biology for drug discovery.
Arrell DK; Terzic A
Clin Pharmacol Ther; 2010 Jul; 88(1):120-5. PubMed ID: 20520604
[TBL] [Abstract][Full Text] [Related]
12. Multidimensional atomic force microscopy for drug discovery: a versatile tool for defining targets, designing therapeutics and monitoring their efficacy.
Lal R; Arnsdorf MF
Life Sci; 2010 Apr; 86(15-16):545-62. PubMed ID: 20359578
[TBL] [Abstract][Full Text] [Related]
13. Structural genomics-impact on biomedicine and drug discovery.
Weigelt J
Exp Cell Res; 2010 May; 316(8):1332-8. PubMed ID: 20211166
[TBL] [Abstract][Full Text] [Related]
14. Live cell imaging for target and drug discovery.
Watson P
Drug News Perspect; 2009 Mar; 22(2):69-79. PubMed ID: 19330166
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of network drug target based on improved model of bipartite graph valuation].
Liu X; Lu P; Zuo X; Chen J; Yang H; Yang Y; Gao Y
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):125-9. PubMed ID: 22737836
[TBL] [Abstract][Full Text] [Related]
16. Druggable targets and targeted drugs: enhancing the development of new therapeutics.
Billingsley ML
Pharmacology; 2008; 82(4):239-44. PubMed ID: 18802381
[TBL] [Abstract][Full Text] [Related]
17. Structural genomics approach to drug discovery for Mycobacterium tuberculosis.
Ioerger TR; Sacchettini JC
Curr Opin Microbiol; 2009 Jun; 12(3):318-25. PubMed ID: 19481971
[TBL] [Abstract][Full Text] [Related]
18. [Advance in the research and discovery of novel drugs based on chemogenomics].
He BK; Ma ZC; Wang YG; Gao Y
Yao Xue Xue Bao; 2008 Nov; 43(11):1077-81. PubMed ID: 19239023
[TBL] [Abstract][Full Text] [Related]
19. Exploiting complexity and the robustness of network architecture for drug discovery.
Hellerstein MK
J Pharmacol Exp Ther; 2008 Apr; 325(1):1-9. PubMed ID: 18202293
[TBL] [Abstract][Full Text] [Related]
20. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
Fischer HP
Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
